| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |